in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Report: American Pacific considering sale?
1:38 PM MDT | October 4, 2013 | Vincent Valk
American Pacific (Las Vegas), the parent company of Ampac Fine Chemicals, is considering a sale of the whole company, according to a Reuters report. KeyBanc (Cleveland) is reportedly advising American Pacific on the matter, although the report did not mention any potential buyers. Ampac Fine Chemicals reported $44.2 million in sales and $5.8 million in profits in the company’s fiscal third-quarter. Ampac Fine Chemicals produces active pharmaceutical ingredients and pharma intermediates, for anti-viral, oncology and central nervous system drugs. American...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee